Nightingale Health Oyj Income Statement

Financials in millions EUR. Fiscal year is July - June.

Millions EUR. Fiscal year is Jul - Jun.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021
Revenue	4.8	4.69	4.36	4.18	2.31	2.31
Revenue Growth (YoY)	-3.15%	7.69%	4.21%	80.80%	0.35%	29.43%
Cost of Revenue	1.57	1.16	1.46	0.59	1.04	0.32
Gross Profit	3.23	3.54	2.9	3.59	1.28	1.99
Selling, General & Admin	8.71	8.6	8.78	9.38	6.5	6.37
Other Operating Expenses	6.23	6.03	4.51	6.01	4.14	3.05
Operating Expenses	22.26	22.92	21.46	22.08	14.89	11.87
Operating Income	-19.03	-19.38	-18.56	-18.49	-13.61	-9.88
Interest Expense	-1.16	-0.01	-0.01	-0	-0.77	-0.37
Interest & Investment Income	0.19	-	-	-	-	-
Earnings From Equity Investments	-0.06	-0.04	-0.03	-0.03	-0.02	0.13
Currency Exchange Gain (Loss)	-0.15	-0.15	-0.27	-0.37	0.3	-0.06
Other Non Operating Income (Expenses)	1.18	1.17	1.5	0.82	-0.03	0.46
EBT Excluding Unusual Items	-19.03	-18.41	-17.38	-18.07	-14.13	-9.72
Gain (Loss) on Sale of Investments	-	-	-	-	-2.07	-
Pretax Income	-19.03	-18.41	-17.38	-18.07	-16.19	-9.72
Income Tax Expense	0.05	0.05	0.09	0.01	-0.1	0
Net Income	-19.07	-18.46	-17.46	-18.08	-16.09	-9.73
Net Income to Common	-19.07	-18.46	-17.46	-18.08	-16.09	-9.73
Shares Outstanding (Basic)	60	60	60	60	60	42
Shares Outstanding (Diluted)	60	60	60	60	60	42
Shares Change (YoY)	0.02%	0.01%	-	0.17%	44.56%	22.85%
EPS (Basic)	-0.32	-0.31	-0.29	-0.30	-0.27	-0.23
EPS (Diluted)	-0.32	-0.31	-0.29	-0.30	-0.27	-0.23
Free Cash Flow	-13.4	-12.39	-10.62	-8.16	-8.85	-2.77
Free Cash Flow Per Share	-0.22	-0.20	-0.18	-0.14	-0.15	-0.07
Gross Margin	67.36%	75.39%	66.45%	85.89%	55.17%	86.16%
Operating Margin	-396.83%	-412.95%	-425.86%	-442.16%	-588.46%	-428.59%
Profit Margin	-397.77%	-393.37%	-400.71%	-432.40%	-695.68%	-421.91%
Free Cash Flow Margin	-279.35%	-263.90%	-243.62%	-195.17%	-382.49%	-120.04%
EBITDA	-16.34	-14.5	-14.06	-14.96	-11.53	-9.3
D&A For EBITDA	2.69	4.88	4.5	3.53	2.08	0.58
EBIT	-19.03	-19.38	-18.56	-18.49	-13.61	-9.88

Source: S&P Global Market Intelligence. Standard template. Financial Sources.